| 证券代码 | BSTG.O |
| 证券名称 | Biostage Inc |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2013-11-01 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | Biostage, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 84 October Hill Road, Suite 11, Holliston, Massachusetts, USA |
| 成立日期 | 2012-05-03 |
| 董事会主席 | John F. Kennedy |
| 公司属地 | United States 美国 |
| 公司网址 | www.biostage.com |
| 电话 | +1 (774) 233-7300 |
| 传真 | +1 (774) 233-7302 |
| 公司简介 | Biostage, Inc. is a biotechnology company developing bioengineered organ implants based on the Company’s new Cellframe technology which combines a proprietary biocompatible scaffold with a patient’s own stem cells to create Cellspan organ implants. Cellspan implants are being developed to treat life-threatening conditions of the esophagus, bronchus or trachea with the hope of dramatically improving the treatment paradigm for patients. Based on its preclinical data, Biostage has selected life-threatening conditions of the esophagus as the initial clinical application of its technology. |